Natural history of aberrant crypt foci: A surgical approach

Diseases of the Colon and Rectum

Volumn 39, Issue 7, 1996, Pages 763-767

  Shpitz, Baruch ^a,b   Hay, Kazuko ^a   Medline, Alan ^c   Bruce, W Robert ^b   Bull, Shelley B ^a   Gallinger, Steven ^a   Stern, Hartley ^a,b,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c Northwestern General Hospital   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Colorectal carcinogenesis; Precursor lesions

Indexed keywords

AZOXYMETHANE; METHYLENE BLUE;

ANIMAL MODEL; ANIMAL TISSUE; CARCINOGENESIS; COLON DISEASE; COLON MUCOSA; COLON TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; ENDOSCOPY; FEMALE; INTESTINE CRYPT; NONHUMAN; RAT;

ADENOMA; ANIMALS; CARCINOMA; CARCINOMA IN SITU; COLON; COLONIC NEOPLASMS; FEMALE; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344;

EID: 0030037367     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02054441     Document Type: Conference Paper

References (19)

1. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987;37:147-51.
2. Vivona A, Shpitz B, Medline A, et al. K-ras mutations in aberrant crypt foci, adenomas, and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis 1993;14:1777-81.
3. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames: Iowa State University Press, 1980:130-4.
4. Tatematsu M, Nagamine Y, Farber E. Redifferentiation as a basis for remodelling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res 1983;43:5049-58.
5. Richards TC. Early changes in the dynamics of crypt cell populations in mouse colon following administration of 1,2-dimethylhydrazine. Cancer Res 1977;37:1680-5.
6. McLellan EA, Bird RP. Specificity study to evaluate induction of aberrant crypts in murine colons. Cancer Res 1988;48:6183-6.
7. McLellan EA, Bird RP. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res 1988;48:6187-92.
8. Pretlow TP, O'Riordan MA, Kolman MF, Jurcisek JA. Colonic aberrant crypts in azoxymethane-treated F344 rats have decreased hexosamidase activity. Am J Pathol 1990;136:13-6.
9. Zhang XM, Stamp D, Minkin S, et al. Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein. J Natl Cancer Inst 1992;84:1026-30.
10. Shivapurkar N, Tang ZC, Alabaster O. The effect of high-risk and low-risk diets on aberrant crypt and colonic tumor formation in Fischer-344 rats. Carcinogenesis 1992;13:887-90.
11. Corpet DE, Stamp D, Medline A, Minkin S, Archer MC, Bruce, WR. Promotion of colonic microadenoma growth in mice and rats fed cooked sugar or cooked casein and fat. Cancer Res 1990;50:6955-8.
12. Rao CV, Tokomo K, Kelloff G, Reddy BS. Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats. Carcinogenesis 1991;12:1051-5.
13. Ullah A, Shamsuddin AM. Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats. Carcinogenesis 1990;11:2219-22.
14. McLellan E, Bird RP. Effect of disulfiram on 1,2-dimethylhydrazine- and azoxymethane-induced aberrant crypt foci. Carcinogenesis 1991;12:969-72.
15. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
16. Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 1991;51:1564-7.
17. Pretlow TP, O'Riordan MA, Pretlow TG, Stellata TA. Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J Cell Biochem 1992;16G(Suppl): 55-62.
18. Roncucci L, Medline A, Bruce WR. Classification of aberrant crypt foci and microadenomas in human colons. Cancer Epidemiol Biomarkers Prev 1991;1:57-60.
19. Tudek B, Bird RP, Bruce WR. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res 1989;49:1236-40.